These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 10501313

  • 1. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae.
    Widdowson CA, Klugman KP.
    Semin Respir Infect; 1999 Sep; 14(3):255-68. PubMed ID: 10501313
    [Abstract] [Full Text] [Related]

  • 2. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?
    Doern GV, Richter SS, Miller A, Miller N, Rice C, Heilmann K, Beekmann S.
    Clin Infect Dis; 2005 Jul 15; 41(2):139-48. PubMed ID: 15983908
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB, Fernandes LA, Fernandes CJ.
    Pathology; 2006 Aug 15; 38(4):343-8. PubMed ID: 16916725
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.
    Canton R, Morosini M, Enright MC, Morrissey I.
    J Antimicrob Chemother; 2003 Dec 15; 52(6):944-52. PubMed ID: 14585861
    [Abstract] [Full Text] [Related]

  • 8. Resistance among Streptococcus pneumoniae: Implications for drug selection.
    Appelbaum PC.
    Clin Infect Dis; 2002 Jun 15; 34(12):1613-20. PubMed ID: 12032897
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae.
    Daporta MT, Muñoz Bellido JL, Guirao GY, Hernández MS, García-Rodríguez JA.
    Int J Antimicrob Agents; 2004 Aug 15; 24(2):185-7. PubMed ID: 15288320
    [Abstract] [Full Text] [Related]

  • 13. New Tn916-related elements causing erm(B)-mediated erythromycin resistance in tetracycline-susceptible pneumococci.
    Cochetti I, Tili E, Vecchi M, Manzin A, Mingoia M, Varaldo PE, Montanari MP.
    J Antimicrob Chemother; 2007 Jul 15; 60(1):127-31. PubMed ID: 17483548
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
    Schurek KN, Adam HJ, Siemens CG, Hoban CJ, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2005 Oct 15; 56(4):769-72. PubMed ID: 16126779
    [Abstract] [Full Text] [Related]

  • 16. Pharmacodynamics of levofloxacin against characterized ciprofloxacin-resistant Streptococcus pneumoniae.
    Lister PD.
    Postgrad Med; 2008 Sep 15; 120(3 Suppl 1):46-52. PubMed ID: 18931471
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations.
    De Vecchi E, Nicola L, Ossola F, Drago L.
    J Antimicrob Chemother; 2009 Apr 15; 63(4):721-7. PubMed ID: 19218275
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M, Higa F, Nakasone C, Shinzato T, Akamine M, Haranaga S, Tateyama M, Nakasone I, Yamane N, Fujita J.
    J Antimicrob Chemother; 2006 Dec 15; 58(6):1279-82. PubMed ID: 17056610
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.